Wearable Device Treats Glioblastoma

Andrew Tobin was diagnosed with glioblastoma in September 2017 and is being treated to fight this aggressive tumor with a wearable device.

Andrew and his wife, Ashley, welcomed twins, Fiona Rae and Declan James, into the world just 18 months ago. Despite being treated for glioblastoma, he still works full time as a Quality Control manager at a local food production facility. Leading up to his diagnosis, Andrew checked into a local hospital with persistent migraines and came out more than a week later after a brain tumor was detected and an emergency craniotomy was performed to remove it from his frontal lobe.

“At first, doctors thought the headaches were caused by tension,” he said. “When they discovered it was a brain tumor, I had the emergency surgery and then started looking at where I was going to go for treatment. I had always heard great things about Henry Ford and I’m very thankful I went there.”

Andrew is currently using an FDA-approved device called Optune®, which creates low-intensity, electric tumor-treating fields. To deliver the fields, four transducer patches are applied to the scalp and connected to the battery-operated device. The low frequency current is thought to disrupt cell division in the tumor and may stop or slow the growth of cancer cells. In some cases, the tumor-treating fields may kill cancer cells. 

As much of a difference as Optune makes for patients like Andrew, brain cancer treatment requires more than a physical effort, according to James Snyder, D.O., neuro-oncologist in the Department of Neurosurgery at Henry Ford Health.

“Having a positive attitude during treatment really does make a world of difference,” Dr. Snyder said. “Mr. Gryebet and Mr. Tobin are both diligent and consistent in wearing the Optune cap, which is hugely important, but even beyond that they maintain a mentality that they will stay strong as they go through treatment. Both are continuing to live their lives to the fullest.”

For him, choosing the right team of healthcare providers has been a crucial part of his journey through GBM treatment.